Home › Compare › JOEY vs EQR

JOEY vs EQR: Dividend Comparison 2026

JOEY yields 500000.00% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JOEY wins by $4.663521010693878e+33M in total portfolio value
10 years
JOEY
JOEY
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full JOEY calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — JOEY vs EQR

📍 JOEY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJOEYEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JOEY + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
JOEY pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JOEY
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, JOEY beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JOEY + EQR for your $10,000?

JOEY: 50%EQR: 50%
100% EQR50/50100% JOEY
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

JOEY
No analyst data
Altman Z
-66.6
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JOEY buys
0
EQR buys
0
No recent congressional trades found for JOEY or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJOEYEQR
Forward yield500000.00% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$4.663521010693878e+33M$47.8K ✓
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓$5,475.61
Total dividends collected$4.6634009849658873e+33M$23.0K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: JOEY vs EQR ($10,000, DRIP)

YearJOEY PortfolioJOEY Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,380$679.82+$50.00M → JOEY
2$233,748,371,262$233,694,859,813.08$13,014$837.25+$233748.36M → JOEY
3$1,021,074,511,412,696$1,020,824,400,655,446.10$14,961$1,036.20+$1021074511.40M → JOEY
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$17,297$1,289.22+$4168597328794.93M → JOEY
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$20,121$1,613.15+$15905475114600664.00M → JOEY
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$23,561$2,030.84+$56718938532531060736.00M → JOEY
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$27,783$2,573.54+$1.8903180743562385e+23M → JOEY
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$33,013$3,284.39+$5.8879981047651824e+26M → JOEY
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$39,547$4,223.51+$1.7140642681147225e+30M → JOEY
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$47,791$5,475.61+$4.663521010693878e+33M → JOEY

JOEY vs EQR: Complete Analysis 2026

JOEY — Stock

Joey New York, Inc., through its subsidiary, RAR Beauty, LLC, manufactures and markets natural skin care and beauty products in the United States and Internationally. The company operates through The LABB, Aesthetic Beauty Bar; and Joey New York Cosmetics divisions. The LABB, Aesthetic Beauty Bar division provides injectable services, which eliminate unwanted wrinkles by performing Botox and filler injections. The company offers its products under the Joey New York brand. It offers its products through retailers, professional salons, spas, and beauty Websites. The company was founded in 1993 and is headquartered in Sunny Isles Beach, Florida.

Full JOEY Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this JOEY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JOEY vs SCHDJOEY vs JEPIJOEY vs OJOEY vs KOJOEY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.